Autolus Therapeutics (AUTL) Other Operating Expenses (2017 - 2026)
Autolus Therapeutics' (AUTL) quarterly Other Operating Expenses came in at $25.3 million in Q4 2025, up 844333.33% on a QoQ basis from -$3000.0 in Q1 2025.
Autolus Therapeutics (AUTL) Other Operating Expenses (2017 - 2026) Analysis & Trends
Autolus Therapeutics (AUTL) has 7 years of Other Operating Expenses data on file, last reported at $25.3 million in Q4 2025.
- Quarterly Other Operating Expenses changed N/A year-over-year to $25.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $25.3 million (up 11456.05% YoY) and the FY2025 annual result came in at $96.4 million, up 43314.8% from the prior year.
- Other Operating Expenses grew to $25.3 million in Q4 2025, from -$3000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $25.3 million in Q4 2025 to a low of -$3.8 million in Q1 2023.
- A 4-year average of $3.5 million and a median of -$123000.0 in 2023 frame the typical range for Other Operating Expenses.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Autolus Therapeutics | 763.37 Mn | 561.74 Mn | 25.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.47 Mn |
| Dec 31, 2025 | 25.33 Mn |
| Mar 31, 2025 | -3,000.00 |
| Sep 30, 2024 | -223,000.00 |
| Jun 30, 2023 | -23,000.00 |
| Mar 31, 2023 | -3.77 Mn |
| Dec 31, 2022 | -515,000.00 |
| Jun 30, 2019 | -2.30 Mn |
| Dec 31, 2018 | 685,000.00 |
| Sep 30, 2018 | 31.75 Mn |
| Jun 30, 2018 | -869,000.00 |
| Dec 31, 2017 | -231,000.00 |